Pharmaceutical News

RSS

Study looks at effects of three levels of vitamin D supplementation in overweight, obese blacks

The current recommended minimum daily dose of vitamin D is not sufficient to restore healthy vitamin D levels in overweight or obese blacks, researchers report.

8 Jul 2015

Women who take stop-smoking drug Zyban during pregnancy give birth to a child with birth defects

The Arentz Law Group is currently investigating cases of birth defects caused by the stop-smoking drug Zyban. Women who have taken Zyban while pregnant, and given birth to a child born with a birth defect, are encouraged to contact the law firm immediately for a free legal consultation.

7 Jul 2015

Aspirin may inhibit the growth of mesothelioma, shows study

Aspirin may inhibit the growth of mesothelioma, an aggressive and deadly asbestos-related cancer, University of Hawai'i Cancer Center researchers have found.

7 Jul 2015

Omega-3 fish oil supplements can improve cardiovascular health of healthy seniors

Bethesda, Md. (July 6, 2015)—Fish oil is one of the most popular dietary supplements in the U.S. because of the perceived cardiovascular benefits of the omega-3 it contains.

7 Jul 2015

People who use anabolic steroids to improve sporting performance experience memory issues

People using anabolic steroids to improve muscle growth and sporting performance are far more likely to experience issues with their memory, according to new research from Northumbria University.

7 Jul 2015

Botanic Choice releases list of top 10 supplements for 2015

Botanic Choice has just released its list of the top 10 most popular supplements for the first half of 2015.

7 Jul 2015

Allergan agrees to acquire exclusive worldwide rights to Merck's CGRP migraine development program

Allergan plc and Merck, known as MSD outside the United States and Canada, today announced that they have entered into an agreement under which Allergan will acquire the exclusive worldwide rights to Merck's investigational small molecule oral calcitonin gene-related peptide (CGRP) receptor antagonists, which are being developed for the treatment and prevention of migraine, subject to expiration or termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (HSR).

7 Jul 2015

EPFL scientists identify lansoprazole as potential candidate against tuberculosis

Testing thousands of approved drugs, EPFL scientists have identified an unlikely anti-tuberculosis drug: the over-the-counter antacid lansoprazole (Prevacid).

7 Jul 2015

Researchers identify link between autoimmune diseases, medications and Long QT syndrome

Mohamed Boutjdir, PhD, professor of medicine, cell biology, and physiology and pharmacology at SUNY Downstate Medical Center, has led a study with international collaborators identifying the mechanism by which patients with various autoimmune and connective tissue disorders may be at risk for life-threatening cardiac events if they take certain anti-histamine or anti-depressant medications.

7 Jul 2015

AOSSM to present awards and grants to encourage cutting-edge research in orthopaedic sports medicine

In order to recognize and encourage cutting-edge research in key areas of orthopaedic sports medicine, the American Orthopaedic Society for Sports Medicine will present ten research awards and seven grants during its Annual Meeting, July 9-12 in Orlando, FL.

7 Jul 2015

MIT researchers reveal key brainwave changes among patients receiving nitrous oxide

Nitrous oxide, commonly known as "laughing gas," has been used in anesthesiology practice since the 1800s, but the way it works to create altered states is not well understood. In a study published this week in Clinical Neurophysiology, MIT researchers reveal some key brainwave changes among patients receiving the drug.

7 Jul 2015

Study could provide paradigm shift in treatment of age-related disease, cancer

Intermittent dosing with rapamycin selectively breaks the cascade of inflammatory events that follow cellular senescence, a phenomena in which cells cease to divide in response to DNA damaging agents, including many chemotherapies.

7 Jul 2015

New therapeutic alternative found for children suffering from Ewing's sarcoma

A research consortium made up of the Virgen del Rocio hospital in Seville, Sant Joan de Deu and the Bellvitge Biomedical Research Institute in Barcelona, has found a new therapeutic alternative for children who suffer from a malignant pediatric tumor bone and soft tissue called Ewing's sarcoma.

7 Jul 2015

Common arthritis drug could help to treat patients with blood cancers

Scientists at the University of Sheffield have discovered that a common drug given to arthritis sufferers could also help to treat patients with blood cancers.

7 Jul 2015

New treatment option available for CLL patients in Manitoba and Saskatchewan

People in Manitoba and Saskatchewan living with Chronic Lymphocytic Leukemia (CLL) will now be able to access a new treatment option through the prescription drug insurance plans in both provinces. Earlier this week, GAZYVA (obinutuzumab) in combination with chlorambucil chemotherapy was added to benefits formularies of the Provincial Oncology Drug Programs at CancerCare Manitoba and the Saskatchewan Cancer Agency.

6 Jul 2015

Akcea Therapeutics obtains FDA Orphan Drug Designation for volanesorsen

Akcea Therapeutics, a wholly-owned subsidiary of Isis Pharmaceuticals, Inc., announced today that the U.S. Food and Drug Administration has granted Orphan Drug Designation to volanesorsen (ISIS-APOCIIIRx) for the treatment of patients with Familial Chylomicronemia Syndrome (FCS).

6 Jul 2015

Redwood Pharma signs licensing agreement with Broda Technologies for hydrogel drug delivery technology

Redwood Pharma AB has entered into a licensing agreement with Broda Technologies Co., Ltd., operating in both the US and China, to use the company's proprietary IntelliGel supramolecular hydrogel technology in its lead chronic Dry Eye therapeutic currently under development and other ophthalmic therapies.

3 Jul 2015

Study: New test may help predict effectiveness of biologic drugs in RA patients

A study of 311 patients by The University of Manchester has found that it may be possible to predict early which rheumatoid arthritis (RA) patients will fail to respond to the biologic drugs given to treat them.

3 Jul 2015

Boehringer Ingelheim’s Spiolto Respimat approved for COPD treatment in first European countries

Boehringer Ingelheim today announced regulatory authority approvals for Spiolto Respimat (tiotropium/olodaterol) in first European countries. Spiolto Respimat is a once-daily maintenance treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD).

3 Jul 2015

Creating more effective vaccines against flu virus

Flu vaccines can be something of a shot in the dark. Not only must they be given yearly, there's no guarantee the strains against which they protect will be the ones circulating once the season arrives. New research by Rockefeller University scientists and their colleagues suggests it may be possible to harness a previously unknown mechanism within the immune system to create more effective and efficient vaccines against this ever-mutating virus.

3 Jul 2015

Pharmaceutical News

Study looks at effects of three levels of vitamin D supplementation in overweight, obese blacks

Women who take stop-smoking drug Zyban during pregnancy give birth to a child with birth defects

Aspirin may inhibit the growth of mesothelioma, shows study

Omega-3 fish oil supplements can improve cardiovascular health of healthy seniors

People who use anabolic steroids to improve sporting performance experience memory issues

Botanic Choice releases list of top 10 supplements for 2015

Allergan agrees to acquire exclusive worldwide rights to Merck's CGRP migraine development program

EPFL scientists identify lansoprazole as potential candidate against tuberculosis

Researchers identify link between autoimmune diseases, medications and Long QT syndrome

AOSSM to present awards and grants to encourage cutting-edge research in orthopaedic sports medicine

MIT researchers reveal key brainwave changes among patients receiving nitrous oxide

Study could provide paradigm shift in treatment of age-related disease, cancer

New therapeutic alternative found for children suffering from Ewing's sarcoma

Common arthritis drug could help to treat patients with blood cancers

New treatment option available for CLL patients in Manitoba and Saskatchewan

Akcea Therapeutics obtains FDA Orphan Drug Designation for volanesorsen

Redwood Pharma signs licensing agreement with Broda Technologies for hydrogel drug delivery technology

Study: New test may help predict effectiveness of biologic drugs in RA patients

Boehringer Ingelheim’s Spiolto Respimat approved for COPD treatment in first European countries

Creating more effective vaccines against flu virus

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Latest News